USPRegulatory IntelligenceGeneral Chapter
USP <1207>

Package Integrity Evaluation — Sterile Products

USP General Chapter <1207> is an informational chapter providing a framework for container closure integrity (CCI) evaluation of sterile pharmaceutical products. It emphasises deterministic (physicochemical) leak-test methods over probabilistic ones, defines the maximum allowable leakage limit concept, and surveys test technologies. Sub-chapters <1207.1>, <1207.2>, and <1207.3> address package integrity in the product lifecycle, leak-test method selection and validation, and package seal quality test methods respectively.

LAST REVISED
August 2016
PRODUCT AREAS
Sterile

What this does not cover

stated in the document's own scope
  • Addresses sterile-product CCI, not general packaging performance
  • Does not set a single universal leakage limit — the MALL is product-specific
  • Does not cover microbiological method validation — see USP <1223>
  • Does not itself mandate a specific test method
SOURCE & PROVENANCE
ISSUING BODY
United States Pharmacopeia
JURISDICTION
United States / International
DOCUMENT ID
USP <1207>
Official site — United States Pharmacopeia

Always verify against the current published text before relying on it for a submission or inspection.

Overview

USP General Chapter <1207> is an informational chapter providing a framework for evaluating container closure integrity (CCI) of sterile pharmaceutical products throughout the product lifecycle. It introduces the concept of a maximum allowable leakage limit, emphasises deterministic (physicochemical) leak-test technologies over probabilistic approaches such as microbial ingress, and surveys available test methods with their sensitivities and appropriate uses. Its sub-chapters address, respectively, package integrity in the product lifecycle (<1207.1>), leak-test method selection and validation (<1207.2>), and package seal quality test methods (<1207.3>).

Legal basis & how it acquires force

As a USP general chapter numbered above 1000, <1207> is informational rather than mandatory of itself. USP-NF chapters become enforceable in the US through incorporation by reference under the FD&C Act where invoked. The applicable regulatory expectation is that sterile products maintain container closure integrity across their shelf life; <1207> provides the framework and vocabulary rather than a standalone binding limit.

Document structure

PartCovers
<1207> main chapterCCI concepts, maximum allowable leakage limit, deterministic vs probabilistic methods
<1207.1>Package integrity considerations across the product lifecycle
<1207.2>Leak-test method selection and validation
<1207.3>Package seal quality test methods

Key requirements

  • Establish the product-specific maximum allowable leakage limit (MALL) concept
  • Favour deterministic leak-test methods over probabilistic (e.g. microbial ingress) methods
  • Select and validate the CCI method appropriate to the package and product
  • Apply CCI verification across the product lifecycle, including stability
  • Characterise package seal quality where relevant to integrity
  • Justify the sensitivity of the chosen method relative to the integrity requirement

Implementation tips

  • It is informational (>1000); the enforceable expectation is a validated, sensitivity-justified CCI program
  • Prefer deterministic methods for release/stability; keep probabilistic methods for method correlation only
  • Map the sub-chapters: <1207.1> lifecycle, <1207.2> method selection, <1207.3> seal quality
  • Tie CCI acceptance to the actual container/closure system, not a generic leakage threshold
CHECKING ACCESS

Checking your Professional access…

International alignment

USP <1207> aligns with PDA technical reports on container closure integrity and with the general regulatory shift toward deterministic CCI methods reflected in FDA and EU sterile-product expectations (including EU GMP Annex 1 lifecycle CCI concepts).

USP <1207>: frequently asked questions

Quick answers to common questions about USP <1207>.

Does <1207> prefer deterministic or probabilistic methods?

It favours deterministic (physicochemical) leak-test methods over probabilistic methods such as microbial ingress.

What are the sub-chapters?

<1207.1> lifecycle, <1207.2> method selection and validation, <1207.3> package seal quality test methods.

What is the maximum allowable leakage limit?

A product-specific leakage threshold below which container closure integrity is considered maintained.